Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2024-12-20 00:00:00 ET · period of report 2024-12-19 · accession 0000950170-24-139063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 2024-12-19 | PHAT | Nabulsi Azmi | COO | S - Sale | $8.00 | -1,118 | 239.3K | -0.5% | -$8,944 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-19 | S | D | 1,118 | $8.00 | 239,303 | D | — | — |